Transactions
Peterson Law represents Revive Therapeutics Ltd. as it closes $3,000,000 Public Offering of units
On December 18, 2014, Revive Therapeutics Ltd. (“Revive”) closed a public offering of 4,996,500 units (“Units”) at a price of $0.60 per Unit for gross proceeds of $2,997,900. Each Unit was comprised of one common share and one warrant entitling the holder thereof to purchase one additional common share for $0.85 for a period of two years from the date of issuance, subject to acceleration under certain circumstances.
Revive’s public offering was led by Beacon Securities Limited (“Beacon”) as the sole agent and bookrunner. Beacon was paid a cash commission and 349,755 compensation options, each such option entitling the holder to purchase one Unit for $0.60 for a period of two years from the date of issuance.
Recent Transactions
Peterson McVicar Acts for Foran in Upsize to Previously Announced Brokered Private Placement to C$100 Million
Peterson McVicar Acts for Probe Gold in $15 Million Bought Deal Private Placement
Peterson McVicar Acts for Red Cloud in C$5.0M Bought Deal Private Placement and Concurrent Non-Brokered Private Placement of C$2.0 Million with Brunswick Exploration
Peterson McVicar Acts for Red Cloud in C$5.0M Bought Deal Private Placement and Concurrent Non-Brokered Private Placement of C$2.0 Million with Brunswick Exploration